Steve Miller - Net Worth and Insider Trading
Steve Miller Net Worth
The estimated net worth of Steve Miller is at least $14 Million dollars as of 2024-09-20. Steve Miller is the Chief Op. & Scientific Officer of Catalyst Pharmaceuticals Inc and owns about 675,124 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $14 Million. Details can be seen in Steve Miller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steve Miller has not made any transactions after 2024-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steve Miller
Steve Miller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steve Miller owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Steve Miller’s form 4 insider trades.
Insider Ownership Summary of Steve Miller
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2024-08-20 | VP Development & Management |
Steve Miller Latest Holdings Summary
Steve Miller currently owns a total of 1 stock. Steve Miller owns 675,124 shares of Catalyst Pharmaceuticals Inc (CPRX) as of August 20, 2024, with a value of $14 Million.
Latest Holdings of Steve Miller
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2024-08-20 | 675,124 | 21.18 | 14,295,751 |
Holding Weightings of Steve Miller
Steve Miller Form 4 Trading Tracker
According to the SEC Form 4 filings, Steve Miller has made a total of 7 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 150,000 shares on August 20, 2024, which brought Steve Miller around $3 Million.
Insider Trading History of Steve Miller
- 1
Steve Miller Trading Performance
GuruFocus tracks the stock performance after each of Steve Miller's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steve Miller is 74.87%. GuruFocus also compares Steve Miller's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steve Miller within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steve Miller's insider trading performs compared to the benchmark.
Performance of Steve Miller
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 57.68 | | | | | |
| Relative Return to S&P 500(%) | 57.91 | | | | | |
Steve Miller Ownership Network
Steve Miller Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Steve Miller is the VP Development & Management of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Commercial Officer Carmen Jeffrey Del , Chief Medical Officer Gary Ingenito , and Chief Compliance/Legal Officer Brian Elsbernd .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Steve Miller made 2 insider transaction in Catalyst Pharmaceuticals Inc (CPRX) with a net sale of 190,000. Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 120,000 shares made by David S Tierney , a net sale of 250,000 shares made by Alicia Grande , and a net sale of 230,000 shares made by Gary Ingenito .
In summary, during the past 3 months, insiders sold 301,058 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 301,058 shares. During the past 18 months, 961,406 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 961,406 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Steve Miller Mailing Address
Above is the net worth, insider trading, and ownership report for Steve Miller. You might contact Steve Miller via mailing address: 220 Miracle Mile, Suite 234, Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
